TRT / RTR Design [RSABE / ABEL]

posted by mittyri – Russia, 2017-05-02 18:38  – Posting: # 17295
Views: 5,803

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

» The appropriate sample size must be.
» Alpha correction.
what did you mean here?

Kind regards,
Mittyri

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,408 posts in 4,123 threads, 1,325 registered users;
online 17 (1 registered, 16 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 12:30 CEST

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5